PRT-063069 is a small molecule being researched as a selective inhibitor of the protein kinase C (PKC) enzyme, specifically targeting the PKCθ isoform. PKCθ plays a key role in immune cell signaling, particularly in T-cell activation and function. By inhibiting PKCθ, PRT-063069 has shown potential for modulating immune responses, which could be beneficial in treating autoimmune diseases and inflammatory conditions. It may also have applications in cancer immunotherapy by altering immune cell behavior.
MedKoo Cat#: 145766
Name: PRT-063069
CAS#: 2514788-36-2
Chemical Formula: C13H12ClN3O6S
Exact Mass: 373.0100
Molecular Weight: 373.76
Elemental Analysis: C, 41.78; H, 3.24; Cl, 9.48; N, 11.24; O, 25.68; S, 8.58
The following data is based on the product molecular weight 373.76 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |